Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.

Autor: Dominique A Caugant, Paul A Kristiansen, Xin Wang, Leonard W Mayer, Muhamed-Kheir Taha, Rasmata Ouédraogo, Denis Kandolo, Flabou Bougoudogo, Samba Sow, Laurence Bonte

Publikováno v: PLoS ONE, Vol 7, Iss 9, p e46019 (2012)

BACKGROUND: The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at ri

Externí odkaz: https://doaj.org/article/f486139256f4424bb540a6fb2564626c

Carriage of Neisseria lactamica in 1- to 29-Year-Old People in Burkina Faso: Epidemiology and Molecular Characterization

Autor: Jennifer Dolan Thomas, Paul A. Kristiansen, Denis Kandolo, Marie-Pierre Préziosi, F. Marc LaForce, Abdoul-Salam Ouédraogo, Rasmata Ouédraogo, Thomas A. Clark, Absatou Ky Ba, Dominique A. Caugant, Idrissa Sanou, Fabien Diomandé, Lassana Sangaré

Publikováno v: Journal of Clinical Microbiology. 50:4020-4027

Neisseria lactamica is a true commensal bacterium occupying the same ecological niche as the pathogenic Neisseria meningitidis , which is responsible for outbreaks and large epidemics, especially in sub-Saharan Africa. To better understand the epidem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d633df75db7ecc57c2d72212560683f4
https://doi.org/10.1128/jcm.01717-12

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

Autor: Marc LaForce, Lassana Sangaré, Jennifer Dolan Thomas, Pascal Kaboré, Rasmata Ouédraogo, Denis Kandolo, Paul A. Kristiansen, Mamoudou Harouna Djingarey, Marie-Pierre Préziosi, Abdoul-Salam Ouédraogo, Thomas A. Clark, Nancy E. Messonnier, Charles D. Ouédraogo, Cynthia Hatcher, Musa Hassan-King, Stanley C. Wei, Fabien Diomandé, Dominique A. Caugant, Idrissa Sanou, Ki Ba Absatou

Publikováno v: Clinical and Vaccine Immunology. 18:435-443

The serogroup A meningococcal conjugate vaccine MenAfriVac has the potential to confer herd immunity by reducing carriage prevalence of epidemic strains. To better understand this phenomenon, we initiated a meningococcal carriage study to determine t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba4326e4f4d6a6087efeb590d320c3c
https://doi.org/10.1128/cvi.00479-10

Public Health Impact After the Introduction of PsA-TT: The First 4 Years

Autor: Kadidja Gamougam, Nehemie Mbakuliyemo, Denis Kandolo, Nancy E. Messonnier, James M. Stuart, F. Marc LaForce, Jean-Marc Collard, Paul A. Kristiansen, Ryan T. Novak, Doumagoum M. Daugla, William Perea, Brian Greenwood, Fabien Diomandé, Carol Tevi-Benissan, Mamoudou Harouna Djingarey, Marie-Pierre Preziosi, O. Walker, Thomas A. Clark, Dominique A. Caugant, Leonard W. Mayer

Publikováno v: Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2015, 61 (suppl_5), pp.S467-S472. ⟨10.1093/cid/civ499⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

International audience; Background. During the first introduction of a group A meningococcal vaccine (PsA-TT) in 2010–2011 and its rollout from 2011 to 2013, >150 million eligible people, representing 12 hyperendemic meningitis countries, have been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f832aac82940364ba93875da5c003
https://researchonline.lshtm.ac.uk/id/eprint/2551457/1/civ499.PMC4639484.pdf

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience

Autor: Desire Toboe, Clement Lingani, Stéphane Hugonnet, Nancy E. Messonier, Richard Mihigo, Denis Kandolo, Leonard W. Mayer, Patrick L.F. Zuber, William Perea, Mete Bonkoungou, F. Marc LaForce, Teresa Aguado, Nora Dellepiane de Rey Tolve, Carole Tevi-Benissan, Marie-Pierre Préziosi, Rodrigue Barry, Rene Sebgo, Mamoudou Harouna Djingarey, Fabien Diomandé, Dominique A. Caugant, Deo Nshimirimana, Monique Berlier, Thomas A. Clark, Sylvestre R. M. Tiendrebéogo, Ryan T. Novak, Paul A. Kristiansen

Publikováno v: Vaccine. 30

A new Group A meningococcal (Men A) conjugate vaccine, MenAfriVac™, was prequalified by the World Health Organization (WHO) in June 2010. Because Burkina Faso has repeatedly suffered meningitis epidemics due to Group A Neisseria meningitidis specia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f015729a90ab8f0f6646334c861fd333
https://pubmed.ncbi.nlm.nih.gov/22607898